XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Common stock
Preferred stock
Nonvested restricted stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings
Total
Beginning balance, value at Dec. 31, 2022 $ 80 $ (3,306) $ 119,027 $ (13,410) $ 192,121 $ 294,512
Beginning balance shares outstanding at Dec. 31, 2022 8,011,045          
Net income 9,259 9,259
Proceeds from exercise of stock options 497 497
Proceeds from exercise of stock options (in Shares) 25,250          
Issuance of restricted stock, net of forfeitures $ 1 (1,824) 1,823
Issuance of restricted stock (in Shares) 52,343          
Compensation expense related to restricted stock, net of tax 1,065 1,065
Compensation expense related to stock options, net of tax 410 410
Other comprehensive income (loss) (1,845) (1,845)
Ending balance, value at Sep. 30, 2023 $ 81 (4,065) 121,757 (15,255) 201,380 303,898
Ending balance shares outstanding at Sep. 30, 2023 8,088,638          
Beginning balance, value at Jun. 30, 2023 $ 81 (4,051) 120,912 (12,710) 197,282 301,514
Beginning balance shares outstanding at Jun. 30, 2023 8,058,438          
Net income 4,098 4,098
Proceeds from exercise of stock options 312 312
Proceeds from exercise of stock options (in Shares) 14,250          
Issuance of restricted stock, net of forfeitures (388) 388
Issuance of restricted stock (in Shares) 15,950          
Compensation expense related to restricted stock, net of tax 374 374
Compensation expense related to stock options, net of tax 145 145
Other comprehensive income (loss) (2,545) (2,545)
Ending balance, value at Sep. 30, 2023 $ 81 (4,065) 121,757 (15,255) 201,380 303,898
Ending balance shares outstanding at Sep. 30, 2023 8,088,638          
Beginning balance, value at Dec. 31, 2023 $ 81 (3,596) 121,777 (11,342) 205,547 312,467
Beginning balance shares outstanding at Dec. 31, 2023 8,088,186          
Net income 9,903 9,903
Proceeds from exercise of stock options 190 190
Proceeds from exercise of stock options (in Shares) 12,000          
Issuance of restricted stock, net of forfeitures $ 1 (2,035) 2,034
Issuance of restricted stock (in Shares) 55,911          
Compensation expense related to restricted stock, net of tax 1,412 1,412
Compensation expense related to stock options, net of tax 287 287
Other comprehensive income (loss) 2,279 2,279
Ending balance, value at Sep. 30, 2024 $ 82 (4,219) 124,288 (9,063) 215,450 326,538
Ending balance shares outstanding at Sep. 30, 2024 8,156,097          
Beginning balance, value at Jun. 30, 2024 $ 82 (4,710) 124,174 (11,866) 211,068 318,748
Beginning balance shares outstanding at Jun. 30, 2024 8,155,097          
Net income 4,382 4,382
Proceeds from exercise of stock options 23 23
Proceeds from exercise of stock options (in Shares) 1,000            
Issuance of restricted stock, net of forfeitures
Compensation expense related to restricted stock, net of tax 491 491
Compensation expense related to stock options, net of tax 91 91
Other comprehensive income (loss) 2,803 2,803
Ending balance, value at Sep. 30, 2024 $ 82 $ (4,219) $ 124,288 $ (9,063) $ 215,450 $ 326,538
Ending balance shares outstanding at Sep. 30, 2024 8,156,097